ATE343574T1 - Ein thiazolidindionderivat und seine verwendung als antidiabetikum - Google Patents
Ein thiazolidindionderivat und seine verwendung als antidiabetikumInfo
- Publication number
- ATE343574T1 ATE343574T1 AT01963244T AT01963244T ATE343574T1 AT E343574 T1 ATE343574 T1 AT E343574T1 AT 01963244 T AT01963244 T AT 01963244T AT 01963244 T AT01963244 T AT 01963244T AT E343574 T1 ATE343574 T1 AT E343574T1
- Authority
- AT
- Austria
- Prior art keywords
- antidiabetic drug
- compound
- thiazolidinedione derivative
- thiazolidinedione
- derivative
- Prior art date
Links
- 229940127003 anti-diabetic drug Drugs 0.000 title 1
- 239000003472 antidiabetic agent Substances 0.000 title 1
- 150000001467 thiazolidinediones Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- VJYJKNKXBSOHFP-TYYBGVCCSA-N (e)-but-2-enedioic acid;1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1.OC(=O)\C=C\C(O)=O VJYJKNKXBSOHFP-TYYBGVCCSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0021978.2A GB0021978D0 (en) | 2000-09-07 | 2000-09-07 | Novel pharmaceutical |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE343574T1 true ATE343574T1 (de) | 2006-11-15 |
Family
ID=9899043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01963244T ATE343574T1 (de) | 2000-09-07 | 2001-09-05 | Ein thiazolidindionderivat und seine verwendung als antidiabetikum |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20040014791A1 (de) |
| EP (1) | EP1315721B1 (de) |
| JP (1) | JP2004508367A (de) |
| KR (1) | KR100769007B1 (de) |
| CN (2) | CN100415741C (de) |
| AT (1) | ATE343574T1 (de) |
| AU (1) | AU2001284274A1 (de) |
| CY (1) | CY1105903T1 (de) |
| DE (1) | DE60124119T2 (de) |
| DK (1) | DK1315721T3 (de) |
| ES (1) | ES2272528T3 (de) |
| GB (1) | GB0021978D0 (de) |
| HK (1) | HK1057204A1 (de) |
| PT (1) | PT1315721E (de) |
| WO (1) | WO2002020517A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
| DE102005034406A1 (de) * | 2005-07-22 | 2007-02-01 | Ratiopharm Gmbh | Neue Salze von Rosiglitazon |
| US7435741B2 (en) | 2006-05-09 | 2008-10-14 | Teva Pharmaceutical Industries, Ltd. | 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
| DE102009053562A1 (de) | 2009-11-18 | 2011-05-19 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Rosiglitazonsuccinat enthaltende pharmazeutische Zusammensetzung |
| US20130158077A1 (en) | 2011-12-19 | 2013-06-20 | Ares Trading S.A. | Pharmaceutical compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2137915T3 (es) | 1987-09-04 | 2000-01-01 | Beecham Group Plc | Derivados de tiazolidindiona sustituida. |
| US5741803A (en) * | 1992-09-05 | 1998-04-21 | Smithkline Beecham Plc | Substituted thiazolidinedionle derivatives |
| GB9218830D0 (en) | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| GB9711683D0 (en) | 1997-06-05 | 1997-08-06 | Smithkline Beecham Plc | Composition |
| GB9726568D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB9726563D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB9726566D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| US6329403B1 (en) * | 1998-06-30 | 2001-12-11 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for the treatment of diabetes |
-
2000
- 2000-09-07 GB GBGB0021978.2A patent/GB0021978D0/en not_active Ceased
-
2001
- 2001-09-05 US US10/363,602 patent/US20040014791A1/en not_active Abandoned
- 2001-09-05 KR KR1020037003415A patent/KR100769007B1/ko not_active IP Right Cessation
- 2001-09-05 DK DK01963244T patent/DK1315721T3/da active
- 2001-09-05 AT AT01963244T patent/ATE343574T1/de not_active IP Right Cessation
- 2001-09-05 WO PCT/GB2001/003979 patent/WO2002020517A1/en active IP Right Grant
- 2001-09-05 CN CNB2005101285907A patent/CN100415741C/zh not_active Expired - Fee Related
- 2001-09-05 JP JP2002525138A patent/JP2004508367A/ja not_active Withdrawn
- 2001-09-05 EP EP01963244A patent/EP1315721B1/de not_active Expired - Lifetime
- 2001-09-05 AU AU2001284274A patent/AU2001284274A1/en not_active Abandoned
- 2001-09-05 PT PT01963244T patent/PT1315721E/pt unknown
- 2001-09-05 DE DE60124119T patent/DE60124119T2/de not_active Expired - Fee Related
- 2001-09-05 ES ES01963244T patent/ES2272528T3/es not_active Expired - Lifetime
- 2001-09-05 CN CNA018180310A patent/CN1471530A/zh active Pending
-
2003
- 2003-10-30 HK HK03107840A patent/HK1057204A1/xx not_active IP Right Cessation
-
2007
- 2007-01-04 CY CY20071100008T patent/CY1105903T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20040014791A1 (en) | 2004-01-22 |
| PT1315721E (pt) | 2007-01-31 |
| CN1471530A (zh) | 2004-01-28 |
| DE60124119T2 (de) | 2007-05-16 |
| JP2004508367A (ja) | 2004-03-18 |
| HK1057204A1 (en) | 2004-03-19 |
| GB0021978D0 (en) | 2000-10-25 |
| AU2001284274A1 (en) | 2002-03-22 |
| CN1814599A (zh) | 2006-08-09 |
| WO2002020517A1 (en) | 2002-03-14 |
| ES2272528T3 (es) | 2007-05-01 |
| EP1315721B1 (de) | 2006-10-25 |
| KR100769007B1 (ko) | 2007-10-22 |
| DE60124119D1 (de) | 2006-12-07 |
| EP1315721A1 (de) | 2003-06-04 |
| DK1315721T3 (da) | 2007-02-19 |
| KR20030031179A (ko) | 2003-04-18 |
| CN100415741C (zh) | 2008-09-03 |
| CY1105903T1 (el) | 2011-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1105354T1 (el) | Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο | |
| ATE343574T1 (de) | Ein thiazolidindionderivat und seine verwendung als antidiabetikum | |
| NZ515166A (en) | Thiazolidinedione derivative and its use as antidiabetic | |
| AP1814A (en) | Tartrate salts of thiazolidinedione derivative. | |
| DK1349855T3 (da) | 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt | |
| ATE329914T1 (de) | Rosiglitazon-edisylate und ihre verwendung als antidiabetika | |
| AP1680A (en) | Thiazolidinedione derivative and its use as antidiabetic. | |
| AP1715A (en) | The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione | |
| AP2002002673A0 (en) | Thiazolidinedione salt for the treatment of diabetes mellitus. | |
| AP1785A (en) | Tartrate salt of thiazolidinedione derivative. | |
| AP2002002684A0 (en) | 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical | |
| CY1107767T1 (el) | Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο | |
| DE60217168D1 (de) | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dion-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff | |
| AP1813A (en) | Tartrate salts of thiazolidinedione derivative. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1315721 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |